Company Overview and News

 
Goldfields takes Finsure merger

2018-01-15 businessnews.com.au
Kalgoorlie-based bank Goldfields Money has agreed to a scrip-based merger with mortgage aggregator Finsure, valuing the combined group at $97.5 million.
Upvote Downvote

 
Firstmac will not extend Goldfields Money offer

2017-11-27 businessnews.com.au
Brisbane-based Firstmac Holdings said today it would not extend its cash takeover offer for Goldfields Money, which has recommended shareholders support an alternative scrip-based merger with mortgage aggregator Finsure.
Upvote Downvote

 
Morning Headlines

2017-11-23 businessnews.com.au
Goldfields Money has offered up a $60 million merger proposal with one of the country’s fastest growing mortgage wholesalers as the alternative to Firstmac’s hostile cash takeover bid. The West
Upvote Downvote

 
Goldfields Money rejects increased Firstmac offer

2017-11-09 businessnews.com.au
The board of Kalgoorlie-based bank Goldfields Money has knocked back a fresh takeover bid from Brisbane financial business Firstmac Holdings, which valued the company at $1.27 per share.
Upvote Downvote

 
Shareholder bids $25m for Goldfields Money

2017-10-16 businessnews.com.au
ASX-listed financial institution Goldfields Money has received a takeover offer from its largest shareholder, which values the target at about $25 million.
Upvote Downvote

 
Stargroup doubles size of Goldfields deal due to ATM growth

2017-05-18 proactiveinvestors.com.au
Stargroup (ASX:STL) and banking services provider Goldfields Money (ASX: GMY) have doubled their existing ATM cash convenience agreement to $30 million for the next three years.
Upvote Downvote

 
Goldfields Money to develop cross-border banking products

2017-04-11 proactiveinvestors.com.au
Goldfields Money (ASX:GMY) has signed an agreement with Singapore based cross-border payments company InstaRem to develop and market cross-border banking applications.
Upvote Downvote

 
Goldfields raises funds for new platform

2017-03-21 businessnews.com.au
Financial services provider Goldfields Money has raised $4.2 million from investors as it launches a new digital platform and completes a rebranding.
Upvote Downvote

 
Goldfields Money to outline raising

2017-03-17 proactiveinvestors.com.au
Goldfields Money (ASX:GMY) has been granted a trading halt by the ASX, with its shares placed in pre-open.
Upvote Downvote

 
Rubik Financial signs deal to deliver innovative financial software

2017-03-02 proactiveinvestors.com.au
Rubik Financial (ASX:RFL) has entered into a partnership with wealth management company Yellow Brick Road (ASX:YBR) to provide Rubik’s innovative financial advice software.
Upvote Downvote

 
Stargroup posts record December half results

2017-02-28 proactiveinvestors.com.au
Stargroup (ASX:STL) has posted record revenue of $4.01 million for the December half, up 228% on the previous corresponding period (pcp).
Upvote Downvote

1
Stargroup Ltd on track for a record December quarter

2016-11-14 proactiveinvestors.com.au
Stargroup Ltd (ASX:STL) is set for yet another record breaking quarter, expecting revenues of over $2 million for the December quarter.
Upvote Downvote

 
Goldfields Money Ltd signs $15M deal to utilise excess cash reserves

2016-09-13 proactiveinvestors.com.au
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.
Upvote Downvote

 
Stargroup Ltd signs deal with Goldfields Money to lower cost of funds

2016-09-13 proactiveinvestors.com.au
Stargroup Ltd (ASX:STL) will reduce its cost of funds after signing a three year, $15 million agreement with authorised deposit-taking institution, Goldfields Money Ltd (ASX:GMY). The ATM Cash Convenience Agreement has an initial limit of $15 million that Stargroup can use for its national ATM network. Stargroup will also provide Goldfields Money with ATM machines to service its customers in remote locations where major banks have withdrawn from.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...